Skip to main content

Eye conditions

Keratoconus: treatment, symptoms, causes and corneal cross-linking

Keratoconus is an eye condition in which the clear front of the eye (the cornea) thins and develops a cone-like bulge, blurring vision. It usually starts in the teens or twenties and often gets gradually worse. Glasses and contact lenses correct vision, and corneal cross-linking can stop it progressing. Moorfields says it does not cause blindness.

Last checked: 2026-10-11

Key facts

At a glance.

  • What it is

    Moorfields Eye Hospital describes keratoconus as a non-inflammatory eye condition in which the cornea progressively thins, causing a cone-like bulge to develop.

  • When it starts

    Moorfields says it normally develops in teenagers or those in their twenties and often gradually gets worse over time.

  • Symptoms

    Worsening vision causing frequent changes to prescription, blurring or clouding of vision, and sensitivity and glare from bright lights.

  • Not blindness

    Moorfields says keratoconus does not cause blindness, and even in advanced cases it is usually possible to correct vision with contact lenses.

  • Stopping progression

    Corneal cross-linking prevents keratoconus getting worse. Moorfields says it is successful in more than 90% of cases, with a small chance (less than 3%) of reduced vision afterwards.

  • Cause

    Moorfields says the exact cause is unknown, though genetic and environmental factors may play a part. Around 1 in 10 people have an affected first-degree relative.

How is keratoconus treated?

Moorfields says that in most cases vision can be improved. Early on, this usually means spectacles or soft contact lenses, and as the disease progresses hard contact lenses are often required. In very advanced cases, where contact lenses no longer work, a corneal transplant may be needed to restore vision.

Moorfields explains that in the past up to about 20% of patients needed a transplant at some point in their life, but corneal cross-linking now allows doctors to intervene early to stop vision loss.

Treatment options for keratoconus (Moorfields Eye Hospital)
StageTypical optionPurpose
EarlyGlasses or soft contact lensesCorrect blur from short sight and astigmatism
ProgressingHard contact lensesGive a smoother optical surface to improve vision
Progressing corneaCorneal cross-linking (CXL)Stiffens the cornea to prevent further worsening
Very advancedCorneal transplantRestores vision when lenses no longer work

Corneal cross-linking: what it is and how well it works

Moorfields describes corneal cross-linking (CXL) as a treatment that prevents keratoconus getting worse. The surface layer of the cornea is gently brushed clear, riboflavin (vitamin B2) drops are applied for at least 10 minutes, and ultraviolet light is then shone for 8 minutes. The light and riboflavin react to create cross links that make the cornea stiffer. It is done as a day case under anaesthetic drops, with no needles or injections, and a soft contact lens is placed on the eye as a bandage until the follow-up visit.

Moorfields says CXL is successful in more than 90% of cases, and that it does not cure keratoconus but locks in the shape the cornea has at the time of treatment. After treatment you will still need glasses or contact lenses. Some people get an improvement in shape and vision, which Moorfields calls a bonus.

Moorfields says the eye will be sore for a few days, vision is often hazy at first and most patients can return to work after one week. It says CXL is safe, but there is a small chance (less than 3%) of reduced vision afterwards.

What are the symptoms of keratoconus?

Moorfields lists worsening vision causing frequent changes to prescription, blurring or clouding of vision, and sensitivity and glare from bright lights. It says early stages can be detected by a local optometrist, and that vision is often unaffected in the very early stages.

The change in shape affects focus, causing short sight (myopia) and astigmatism. In advanced cases some patients develop scarring in the cornea, which can make sight blurred by reducing the light entering the eye.

Moorfields says a small number of patients may experience a sudden, painful loss of vision if fluid from the eye enters a very thin cornea, called hydrops, which settles with time.

What causes keratoconus?

Moorfields says the exact cause remains unknown, though both genetic and environmental factors are believed to have an impact. It estimates that around 1 in 10 people with keratoconus have a first-degree family member also affected, but says it is not typically considered an inherited disease.

It says keratoconus occurs more commonly in people with certain allergic conditions, including asthma and eczema, and is more likely to develop in non-Caucasian ethnicity groups. It says the latest research shows keratoconus is much more common than previously thought, although many cases are mild.

Monitoring and follow-up

Moorfields says that after CXL, evidence shows more than 90% of patients remain stable, but you are monitored for a total of five years. At its stable monitoring clinic, appointments include a vision test and a series of eye scans, and if results are stable you are written to with the details of your next appointment. After about five years of stable results you are discharged back to your community optometrist.

For people not yet treated, Moorfields runs an early keratoconus clinic to diagnose and monitor those with keratoconus to see if they are progressing, using corneal scans, vision tests and spectacle prescription. If a change occurs, it says patients can normally be listed for CXL within a few weeks.

NHS and private pathways in general terms

Keratoconus is usually first suspected by a community optometrist, who refers on to a hospital eye service for corneal scans and consideration of cross-linking. Hospital services monitor those who need it and treat progression on the NHS.

Moorfields states that treatment is also available privately, either self-funded or through private medical insurance. Contact lens fitting for keratoconus is often specialist work, and it is reasonable to ask which lens type suits your stage.

Frequently asked

Questions people ask.

Quick, plain-English answers to the questions we hear most.

  • What is keratoconus?

    Moorfields describes it as an eye condition in which the normally round, dome-shaped cornea progressively thins and develops a cone-like bulge, which impairs the eye's ability to focus.

  • What are the symptoms of keratoconus?

    Moorfields lists worsening vision with frequent prescription changes, blurring or clouding of vision, and sensitivity and glare from bright lights. Vision is often unaffected in the very early stages.

  • Can keratoconus be cured?

    It cannot be reversed, but its progression can be stopped. Moorfields says corneal cross-linking prevents it getting worse in more than 90% of cases, though you will still need glasses or contact lenses.

  • Does keratoconus cause blindness?

    No. Moorfields says keratoconus does not cause blindness, and even in advanced keratoconus it is usually possible to correct vision with contact lenses.

  • What causes keratoconus?

    The exact cause is unknown. Moorfields says genetic and environmental factors may play a part, and it is more common in people with asthma or eczema and in some ethnic groups. About 1 in 10 have an affected close relative.

  • What is corneal cross-linking?

    Moorfields says it is a day-case treatment using riboflavin drops and ultraviolet light to stiffen the cornea and prevent keratoconus getting worse. It takes place under anaesthetic drops with no needles.

  • Is corneal cross-linking safe?

    Moorfields says it is safe, but there is a small chance (less than 3%) of a reduction in vision afterwards. The eye is sore for a few days and most patients return to work after one week.

  • Will I need a corneal transplant?

    Moorfields says that in the past up to about 20% of patients needed a transplant, but cross-linking has changed this. A transplant is only needed in very advanced cases where contact lenses no longer work.

  • At what age does keratoconus start?

    Moorfields says it normally develops in teenagers or those in their twenties and often gradually gets worse. It is normally diagnosed in the late teens or early 20s.

  • How long will I be monitored after cross-linking?

    Moorfields says you are monitored for a total of five years after CXL at its stable monitoring clinic, then discharged back to your community optometrist if results remain stable.

Where this comes from

Sources and checking.

This guide is for information, not medical advice.

Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.

Published 2026-10-11, next review 2027-10-11.